Navigation Links
GPOs Fail to Provide Hospitals and Patients Health Care Savings
Date:10/6/2010

WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- Hospitals spend more each year on medical devices and equipment that are purchased through Group Purchasing Organizations (GPOs) than they would if purchased in the open-market according to a recent study commissioned by the Medical Device Manufacturers Association (MDMA).  The study empirically shows that GPOs fail to deliver on their primary justification for allowing them to receive kickbacks from suppliers, and that they do not in fact reduce costs.

(Logo: http://photos.prnewswire.com/prnh/20070227/DCTU110LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20070227/DCTU110LOGO)

"It is painfully clear that while hospitals and providers are trying to improve care and reduce costs for patients, the supplier-funded GPO model is costing the health care system billions," said MDMA President and CEO Mark Leahey.  "This study proves that GPOs not only fail to bend the cost curve for health care down, they are preventing hospitals and patients from getting the best products at the best prices.

"This study bolsters our argument that Congress must pass legislation that will restore the illegality of kickbacks between suppliers and GPOs," added Leahey.

The study, "Do Group Purchasing Organizations Achieve the Best Prices for Member Hospitals? An Empirical Analysis of Aftermarket Transactions," found that repealing the safe harbor statutes Congress passed in 1986 would reduce private U.S. health care expenditures by up to $25 billion each year.  This would also reduce federal health care spending by approximately $11.5 billion annually.  Aftermarket transactions show that GPO member hospitals and health care providers would save up to $37.5 billion based on 2010's most recent data.

Other key findings of the study include:

  • Hospitals saved an average of 10 percent between 2001 through 2010 when they purchased medical devices aftermarket, when GPOs supposedly negotiated the best price;
  • In 2010, the savings for hospitals was up to 18 percent for aftermarket purchases.

This groundbreaking study follows a 2009 report that showed hospitals could save approximately $8 billion each year if the safe harbor provisions were removed for GPOs.

GPOs were established to save hospitals money on the purchase of supplies and equipment. For decades hospitals funded these GPOs. However, with the creation of a safe harbor by Congress in 1986, the GPOs became reliant on suppliers for funding.

The Congressional exemption allows GPOs to legally collect fees from suppliers to whom they award contracts. Contractual arrangements that have evolved between GPOs and their hospital customers frequently exclude competitive medical technologies that could help patients and allow hospitals to reduce costs.

The full study is available at www.medicaldevices.org.

MDMA is a national trade association based in Washington, DC, representing hundreds of innovative, entrepreneurial companies in the medical device industry. MDMA seeks to improve the quality of patient care by encouraging the development of new medical technologies and fostering the availability of innovative products in the marketplace.


'/>"/>
SOURCE Medical Device Manufacturers Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
2. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
3. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
4. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
5. Raptor Pharmaceuticals Provides Update of Product Programs
6. Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay
7. Arbios Provides Clinical Strategy for SEPET(TM) Pivotal Trial
8. Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
9. Most Women With HIV and Their Health Care Providers Have Not Discussed How HIV Might Affect Them Differently Than Men
10. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
11. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017  Cogentix Medical, ... focused on providing the Urology, Uro/Gyn and Gynecology ... that Ash Keswani has joined the Company as ... this newly created position, Mr. Keswani will report ... CEO. "Our organization is delighted that ...
(Date:4/20/2017)... April 20, 2017 Research and Markets has ... Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of ... ... delivery technologies will rise from USD 20 Billion in 2015 to ... Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market ...
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
Breaking Medicine Technology:
(Date:4/21/2017)... , ... April 21, 2017 , ... Providing broad access ... in opposition, but there is a better way to address this problem. , That ... of Pharmacy, Public Policy and Economics at the University of Southern California, who served ...
(Date:4/21/2017)... ... , ... Brady (NYSE:BRC), a global leader in industrial and safety ... vinyl label materials received certification for the BS5609 British Marine Standard. This internationally ... legible, for use on chemical drums shipped by sea. , “Achieving BS5609 ...
(Date:4/21/2017)... ... April 21, 2017 , ... The VIA Agency , ... for Theravent, Inc. , the makers of a revolutionary new device clinically ... is now working to expand distribution in anticipation of a national launch. VIA ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... announced an exciting new partnership with the highly regarded and well renowned Asian ... highly innovative, myTAP & myTAP PAP Nasal Pillow Mask, and will stabilize and ...
(Date:4/21/2017)... ... April 21, 2017 , ... BrightStar Care Salt Lake City, a home ... of Utah (APCUT) and has appointed Rex Wheeler as its new Director of Business ... our agency and our ability to provide quality care to the community,” said Tammara ...
Breaking Medicine News(10 mins):